Revolution Medicines (RVMD) is up 11.5%, or $5.72 to $55.40.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Revolution Medicines price target raised to $80 from $78 at BofA
- Morning Movers: Regional banks in focus after reporting Q3 results
- Revolution Medicines price target raised to $76 from $72 at Raymond James
- Revolution Medicines Receives FDA Voucher for Daraxonrasib
- Promising Prospects for Revolution Medicines: Buy Rating Affirmed on Daraxonrasib’s CNPV Designation